Literature DB >> 9987474

Deaths attributable to Alzheimer's disease in the United States.

D C Ewbank1.   

Abstract

OBJECTIVES: This study provided 2 estimates of the number of deaths attributable to Alzheimer's disease in the United States.
METHODS: One estimate was based on data from the East Boston, Mass, study. The second was based on a simulation using population-based estimates of prevalence and separate estimates of excess death by duration of disease.
RESULTS: Despite different methods and very different estimates of prevalence, these 2 methods led to very similar estimates of 173,000 and 163,000 excess deaths.
CONCLUSIONS: These estimates suggest that 7.1% of all deaths in the United States in 1995 are attributable to Alzheimer's disease, placing it on a par with cerebrovascular diseases as the third leading cause of death.

Entities:  

Mesh:

Year:  1999        PMID: 9987474      PMCID: PMC1508512          DOI: 10.2105/ajph.89.1.90

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  22 in total

1.  A description of the extreme aged population based on improved Medicare enrollment data.

Authors:  B Kestenbaum
Journal:  Demography       Date:  1992-11

2.  From senility to Alzheimer's disease: the rise of the Alzheimer's disease movement.

Authors:  P Fox
Journal:  Milbank Q       Date:  1989       Impact factor: 4.911

3.  Estimated prevalence of dementia among elderly black and white community residents.

Authors:  A Heyman; G Fillenbaum; B Prosnitz; K Raiford; B Burchett; C Clark
Journal:  Arch Neurol       Date:  1991-06

4.  Population prevalence estimates from complex samples.

Authors:  L A Beckett; P A Scherr; D A Evans
Journal:  J Clin Epidemiol       Date:  1992-04       Impact factor: 6.437

5.  Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported.

Authors:  D A Evans; H H Funkenstein; M S Albert; P A Scherr; N R Cook; M J Chown; L E Hebert; C H Hennekens; J O Taylor
Journal:  JAMA       Date:  1989-11-10       Impact factor: 56.272

6.  Mild senile dementia of the Alzheimer type. 4. Evaluation of intervention.

Authors:  L Berg; J P Miller; J Baty; E H Rubin; J C Morris; G Figiel
Journal:  Ann Neurol       Date:  1992-03       Impact factor: 10.422

7.  Survival of outpatients with Alzheimer-type dementia.

Authors:  J S Walsh; H G Welch; E B Larson
Journal:  Ann Intern Med       Date:  1990-09-15       Impact factor: 25.391

8.  Frequency and distribution of Alzheimer's disease in Europe: a collaborative study of 1980-1990 prevalence findings. The EURODEM-Prevalence Research Group.

Authors:  W A Rocca; A Hofman; C Brayne; M M Breteler; M Clarke; J R Copeland; J F Dartigues; K Engedal; O Hagnell; T J Heeren
Journal:  Ann Neurol       Date:  1991-09       Impact factor: 10.422

9.  Risk of death from Alzheimer's disease in a community population of older persons.

Authors:  D A Evans; L A Smith; P A Scherr; M S Albert; H H Funkenstein; L E Hebert
Journal:  Am J Epidemiol       Date:  1991-08-15       Impact factor: 4.897

10.  Prevalence of clinically diagnosed Alzheimer's disease and other dementing disorders: a door-to-door survey in Appignano, Macerata Province, Italy.

Authors:  W A Rocca; S Bonaiuto; A Lippi; P Luciani; F Turtù; F Cavarzeran; L Amaducci
Journal:  Neurology       Date:  1990-04       Impact factor: 9.910

View more
  12 in total

1.  Toxic fibrillar oligomers of amyloid-β have cross-β structure.

Authors:  James C Stroud; Cong Liu; Poh K Teng; David Eisenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-30       Impact factor: 11.205

2.  Correlation of cognitive and masticatory function in Alzheimer's disease.

Authors:  Camila Heitor Campos; Giselle Rodrigues Ribeiro; José Luiz Riani Costa; Renata Cunha Matheus Rodrigues Garcia
Journal:  Clin Oral Investig       Date:  2016-07-30       Impact factor: 3.573

3.  In vitro studies of amyloid beta-protein fibril assembly and toxicity provide clues to the aetiology of Flemish variant (Ala692-->Gly) Alzheimer's disease.

Authors:  D M Walsh; D M Hartley; M M Condron; D J Selkoe; D B Teplow
Journal:  Biochem J       Date:  2001-05-01       Impact factor: 3.857

4.  End-of Life Issues in the Context of Alzheimer's Disease.

Authors:  Rebecca S Allen; Jung Kwak; Kristine L Lokken; William E Haley
Journal:  Alzheimers Care Q       Date:  2003-10-01

5.  Predictors of mortality in nursing home residents with advanced dementia.

Authors:  Kathryn L Hicks; Peter V Rabins; Betty S Black
Journal:  Am J Alzheimers Dis Other Demen       Date:  2010-07-02       Impact factor: 2.035

Review 6.  Barriers to excellent end-of-life care for patients with dementia.

Authors:  Greg A Sachs; Joseph W Shega; Deon Cox-Hayley
Journal:  J Gen Intern Med       Date:  2004-10       Impact factor: 5.128

7.  Alzheimer's disease: Current Trends in Wales.

Authors:  Ganiy Opeyemi Abdulrahman
Journal:  Oman Med J       Date:  2014-07

8.  Synthesis and Purification of Highly Hydrophobic Peptides Derived from the C-Terminus of Amyloid β-Protein.

Authors:  M M Condron; B H Monien; G Bitan
Journal:  Open Biotechnol J       Date:  2008-01-01

9.  Contribution of Alzheimer disease to mortality in the United States.

Authors:  Bryan D James; Sue E Leurgans; Liesi E Hebert; Paul A Scherr; Kristine Yaffe; David A Bennett
Journal:  Neurology       Date:  2014-03-05       Impact factor: 9.910

10.  Comparison of persistence rates of acetylcholine-esterase inhibitors in a state Medicaid program.

Authors:  Susan M Abughosh; Stephen J Kogut
Journal:  Patient Prefer Adherence       Date:  2008-02-02       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.